Phosphorylation of BRN2 Modulates Its Interaction with the Pax3 Promoter To Control Melanocyte Migration and Proliferation

REFERENCES

• Abdel-Malek ZA, et al. 2001. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes. J. Cell Sci. 114:1019–1024.
   PubMedGoogle Scholar
• Alazard R, et al. 2005. Identification of the ‘NORE’ (N-Oct-3 responsive element), a novel structural motif and composite element. Nucleic Acids Res. 33:1513–1523.
   PubMedGoogle Scholar
• Andersen B, Rosenfeld MG. 2001. POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr. Rev. 22:2–35.
   PubMed Web of Science ®Google Scholar
• Arozarena I, et al. 2011. Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A. Cancer Cell 19:45–57.
   PubMed Web of Science ®Google Scholar
• Augustijn KD, et al. 2002. Structural characterization of the PIT-1/ETS-1 interaction: PIT-1 phosphorylation regulates PIT-1/ETS-1 binding. Proc. Natl. Acad. Sci. U. S. A. 99:12657–12662.
   PubMed Web of Science ®Google Scholar
• Barr FG, et al. 1999. Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines. Cancer Res. 59:5443–5448.
   PubMedGoogle Scholar
• Bennett DC, et al. 1989. Cloned mouse melanocyte lines carrying the germline mutations albino and brown: complementation in culture. Development 105:379–385.
   PubMedGoogle Scholar
• Berlin I, et al. 2012. General strategy to analyse coat colour phenotypes in mice. Pigment Cell Melanoma Res. 25:117–119.
   PubMedGoogle Scholar
• Blake JA, Ziman MR. 2005. Pax3 transcripts in melanoblast development. Dev. Growth Differ. 47:627–635.
   PubMedGoogle Scholar
• Boyle GM, et al. 2011. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell Melanoma Res. 24:525–537.
   PubMed Web of Science ®Google Scholar
• Cabos-Siguier B, et al. 2009. Expression and purification of human full-length N Oct-3, a transcription factor involved in melanoma growth. Protein Expr. Purif. 64:39–46.
   PubMedGoogle Scholar
• Carreira S, et al. 2005. Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 433:764–769.
   PubMed Web of Science ®Google Scholar
• Carreira S, et al. 2006. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20:3426–3439.
   PubMed Web of Science ®Google Scholar
• Castro DS, et al. 2006. Proneural bHLH and Brn proteins coregulate a neurogenic program through cooperative binding to a conserved DNA motif. Dev. Cell 11:831–844.
   PubMedGoogle Scholar
• Colombo S, Champeval D, Rambow F, Larue L. 2012. Transcriptomic analysis of mouse embryonic skin cells reveals previously unreported genes expressed in melanoblasts. J. Invest. Dermatol. 132:170–178.
   PubMedGoogle Scholar
• Colombo S, Kumasaka M, Lobe C, Larue L. 2010. Genomic localization of the Z/EG transgene in the mouse genome. Genesis 48:96–100.
   PubMedGoogle Scholar
• Cook AL, Sturm RA. 2008. POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis. Pigment Cell Melanoma Res. 21:611–626.
   PubMedGoogle Scholar
• Delmas V, et al. 2007. Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev. 21:2923–2935.
   PubMed Web of Science ®Google Scholar
• Delmas V, Martinozzi S, Bourgeois Y, Holzenberger M, Larue L. 2003. Cre-mediated recombination in the skin melanocyte lineage. Genesis 36:73–80.
   PubMedGoogle Scholar
• Diamond SE, Chiono M, Gutierrez-Hartmann A. 1999. Reconstitution of the protein kinase A response of the rat prolactin promoter: differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1. Mol. Endocrinol. 13:228–238.
   PubMedGoogle Scholar
• French AD, et al. 2009. PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. Int. J. Med. Sci. 6:93–101.
   PubMed Web of Science ®Google Scholar
• Gallagher SJ, et al. 2011. General strategy to analyse melanoma in mice. Pigment Cell Melanoma Res. 24:987–988.
   PubMedGoogle Scholar
• Goodall J, et al. 2008. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Cancer Res. 68:7788–7794.
   PubMed Web of Science ®Google Scholar
• Goodall J, et al. 2004. Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin. Mol. Cell. Biol. 24:2915–2922.
   PubMedGoogle Scholar
• Goodall J, et al. 2004. The Brn-2 transcription factor links activated BRAF to melanoma proliferation. Mol. Cell. Biol. 24:2923–2931.
   PubMedGoogle Scholar
• Hagino-Yamagishi K, et al. 1997. Predominant expression of Brn-2 in the postmitotic neurons of the developing mouse neocortex. Brain Res. 752:261–268.
   PubMedGoogle Scholar
• Hanke T, Szawlowski P, Randall RE. 1992. Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. J. Gen. Virol. 73(Pt. 3):653–660.
   PubMedGoogle Scholar
• Hara Y, Rovescalli AC, Kim Y, Nirenberg M. 1992. Structure and evolution of four POU domain genes expressed in mouse brain. Proc. Natl. Acad. Sci. U. S. A. 89:3280–3284.
   PubMed Web of Science ®Google Scholar
• Hirobe T, Abe H. 1999. Genetic and epigenetic control of the proliferation and differentiation of mouse epidermal melanocytes in culture. Pigment Cell Res. 12:147–163.
   PubMedGoogle Scholar
• Hodgkinson CA, et al. 1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74:395–404.
   PubMed Web of Science ®Google Scholar
• Kapiloff MS, Farkash Y, Wegner M, Rosenfeld MG. 1991. Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 253:786–789.
   PubMedGoogle Scholar
• Kasibhatla S, et al. 1999. Jun kinase phosphorylates and regulates the DNA binding activity of an octamer binding protein, T-cell factor beta1. Mol. Cell. Biol. 19:2021–2031.
   PubMedGoogle Scholar
• Kobi D, et al. 2010. Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene. Pigment Cell Melanoma Res. 23:404–418.
   PubMedGoogle Scholar
• Kubic JD, Young KP, Plummer RS, Ludvik AE, Lang D. 2008. Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease. Pigment Cell Melanoma Res. 21:627–645.
   PubMed Web of Science ®Google Scholar
• Larue L, Dougherty N, Porter S, Mintz B. 1992. Spontaneous malignant transformation of melanocytes explanted from Wf/Wf mice with a Kit kinase-domain mutation. Proc. Natl. Acad. Sci. U. S. A. 89:7816–7820.
   PubMedGoogle Scholar
• Lee M, Goodall J, Verastegui C, Ballotti R, Goding CR. 2000. Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J. Biol. Chem. 275:37978–37983.
   PubMedGoogle Scholar
• Lefort K, Rouault JP, Tondereau L, Magaud JP, Dore JF. 2001. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells. Oncogene 20:7375–7385.
   PubMedGoogle Scholar
• Luciani F, et al. 2011. Biological and mathematical modeling of melanocyte development. Development 138:3943–3954.
   PubMedGoogle Scholar
• Mackenzie MA, Jordan SA, Budd PS, Jackson IJ. 1997. Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev. Biol. 192:99–107.
   PubMed Web of Science ®Google Scholar
• Medic S, Rizos H, Ziman M. 2011. Differential PAX3 functions in normal skin melanocytes and melanoma cells. Biochem. Biophys. Res. Commun. 411:832–837.
   PubMedGoogle Scholar
• Milewski RC, et al. 2004. Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3. Development 131:829–837.
   PubMedGoogle Scholar
• Moore R, et al. 2004. Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation. Oncogene 23:6726–6735.
   PubMed Web of Science ®Google Scholar
• Moriyama M, et al. 2006. Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J. Cell Biol. 173:333–339.
   PubMed Web of Science ®Google Scholar
• Nakai S, et al. 1995. The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Dev. 9:3109–3121.
   PubMedGoogle Scholar
• Nakatani Y, Ogryzko V. 2003. Immunoaffinity purification of mammalian protein complexes. Methods Enzymol. 370:430–444.
   PubMed Web of Science ®Google Scholar
• Nieto L, et al. 2007. Differential effects of phosphorylation on DNA binding properties of N Oct-3 are dictated by protein/DNA complex structures. J. Mol. Biol. 370:687–700.
   PubMedGoogle Scholar
• Novak A, Guo C, Yang W, Nagy A, Lobe CG. 2000. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 28:147–155.
   PubMed Web of Science ®Google Scholar
• Pinner S, et al. 2009. Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res. 69:7969–7977.
   PubMedGoogle Scholar
• Relaix F, et al. 2003. The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo. Genes Dev. 17:2950–2965.
   PubMedGoogle Scholar
• Reményi A, et al. 2001. Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol. Cell 8:569–580.
   PubMedGoogle Scholar
• Scholl FA, et al. 2001. PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res. 61:823–826.
   PubMedGoogle Scholar
• Schonemann MD, et al. 1995. Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev. 9:3122–3135.
   PubMedGoogle Scholar
• Schouwey K, et al. 2007. Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner. Dev. Dyn. 236:282–289.
   PubMed Web of Science ®Google Scholar
• Schwahn DJ, Xu W, Herrin AB, Bales ES, Medrano EE. 2001. Tyrosine levels regulate the melanogenic response to alpha-melanocyte-stimulating hormone in human melanocytes: implications for pigmentation and proliferation. Pigment Cell Res. 14:32–39.
   PubMedGoogle Scholar
• Segil N, Roberts SB, Heintz N. 1991. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. Science 254:1814–1816.
   PubMedGoogle Scholar
• Strub T, et al. 2011. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 30:2319–2332.
   PubMedGoogle Scholar
• Swope VB, Medrano EE, Smalara D, Abdel-Malek ZA. 1995. Long-term proliferation of human melanocytes is supported by the physiologic mitogens alpha-melanotropin, endothelin-1, and basic fibroblast growth factor. Exp. Cell Res. 217:453–459.
   PubMed Web of Science ®Google Scholar
• Tamura A, et al. 1987. Normal murine melanocytes in culture. In Vitro Cell Dev. Biol. 23:519–522.
   PubMedGoogle Scholar
• Thomson JA, et al. 1995. The Brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. Oncogene 11:691–700.
   PubMedGoogle Scholar
• Thurber AE, et al. 2011. Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway. Oncogene 30:3036–3048.
   PubMedGoogle Scholar
• Vierbuchen T, et al. 2010. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463:1035–1041.
   PubMed Web of Science ®Google Scholar
• Wang Q, Kumar S, Slevin M, Kumar P. 2006. Functional Analysis of Alternative Isoforms of the Transcription Factor PAX3 in Melanocytes In vitro. Cancer Res. 66:8574–8580.
   PubMedGoogle Scholar
• Wellbrock C, et al. 2008. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One 3:e2734.
   PubMed Web of Science ®Google Scholar
• Zhu BK, Pruitt SC. 2005. Determination of transcription factors and their possible roles in the regulation of Pax3 gene expression in the mouse B16 F1 melanoma cell line. Melanoma Res. 15:363–373.
   PubMedGoogle Scholar